19
Participants
Start Date
May 31, 2008
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
placebo/escitalopram
Subjects will first complete a one week, single-blind placebo lead in phase. Subjects will then receive escitalopram for 8 weeks. Subjects will receive 10 mg/day for the first 2 weeks of active treatment, and then 20 mg/day for the remaining 6 weeks of treatment. Medication will be dispensed on a weekly basis.
Oregon Health & Science University, Portland
Collaborators (1)
Forest Laboratories
INDUSTRY
Oregon Health and Science University
OTHER